Sign Up Today and Learn More About Nextgen Bioscience Stock
Invest in or calculate the value of your shares in Nextgen Bioscience or other pre-IPO companies through EquityZen's platform.
Nextgen Bioscience Stock
Nextgen Bioscience is a pharmaceutical company engaged in clinical trials for a therapeutic drug tailored to address fibrosis treatment.
About Nextgen Bioscience Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
Nextgen Bioscience Press Mentions
Stay in the know about the latest news on Nextgen Bioscience
Nextgen Bioscience reports new S1P1 and S1P4 receptor antagonists
bioworld • May 22, 2026
SK Chemicals bolsters new drug development through open innovation
koreaherald • Dec 26, 2025
Nextgen Bioscience patents compounds acting as HIF-1α or VEGFR inhibitors
bioworld • Mar 05, 2024
HIF-1α inhibitors revealed in Nextgen Bioscience patent
bioworld • Feb 19, 2024
Nextgen Bioscience Management
Leadership team at Nextgen Bioscience
CEO
Bongyong Lee
Join now and verify your accreditation status to gain access to:
- Nextgen Bioscience Current Valuation
- Nextgen Bioscience Stock Price
- Nextgen Bioscience Management
- Available deals in Nextgen Bioscience and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nextgen Bioscience Cap Table and Funding History by Share Class and Liquidity Preferences
- Nextgen Bioscience Revenue and Financials
- Nextgen Bioscience Highlights
- Nextgen Bioscience Business Model
- Nextgen Bioscience Risk Factors
- Nextgen Bioscience Research Report from SACRA Research
Trading Nextgen Bioscience Stock
How to invest in Nextgen Bioscience stock?
Accredited investors can buy pre-IPO stock in companies like Nextgen Bioscience through EquityZen funds. These investments are made available by existing Nextgen Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Nextgen Bioscience stock?
Shareholders can sell their Nextgen Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."